Aeternum Health Inc.

What they do

The company's current operations are in transportation electrification, operating 60 truck stop electrification (TSE) facilities with approximately 1,800 electrified parking spaces across 31 states, plus over 300 EV charging connection points. It provides electric power for hotel loads and standby transport refrigeration units, helping fleets reduce diesel idling. The company is divesting this business following a merger agreement with Aeternum Health LLC, which will shift focus to peptide-based longevity treatments.

Revenue drivers

• Truck Stop Electrification (TSE) — Core business providing electric power for hotel loads (HVAC, appliances) at truck stops, generating revenue per connection; 60 facilities and 1,800 spaces.
• Electric Vehicle (EV) Charging Stations — Additional revenue from over 300 EV charging plugs sold or controlled, with potential upgrades to revenue-producing stations.
• Grants and Incentives — Non-dilutive government grants for infrastructure upgrades; awarded grants total ~$810,500 (Washington, Tennessee, North Carolina, Oregon, California) plus more pending.

Recent performance

For the three months ended March 31, 2026, revenue was $2,260, down 98.6% from $164,657 in the prior-year quarter, with a gross margin of ($11,977) versus $125,352. Net loss for fiscal 2025 was $337,094, improving from $450,318 in 2024, and operating cash flow was near breakeven at -$2,958 in 2025. As of March 31, 2026, the company had no cash, total liabilities of $2.1 million, and negative shareholder equity of $2.1 million.

Strategy

Management is executing a strategic pivot to healthcare, specifically longevity and anti-aging, through the merger with Aeternum Health LLC. The plan includes divesting the transportation electrification business and integrating Aeternum's peptide-based treatment intellectual property and commercialization business. The company will issue 51% ownership and 2,000,000 Series B preferred shares to Aeternum's manager, with at least $1.5 million in cash contributed. The merger is subject to closing conditions, including audited financials of Aeternum Health.

Risks

• Pending Merger Risk — The merger with Aeternum Health is not completed and may fail if closing conditions, such as audited financials, are not met.
• Severe Liquidity Risk — Zero cash and negative shareholder equity as of March 31, 2026, indicating immediate need for capital or merger proceeds.
• Revenue Decline — Quarterly revenue collapsed 98.6% year-over-year, reflecting the wind-down of the electrification business.
• Competitive Pressure — In EV charging, faces established competitors like ChargePoint, Tesla, and Electrify America, which may limit market share.

Outlook

Management expects to close the Aeternum Health merger and shift to healthcare, but no timeline is provided beyond customary conditions. The company will process invoicing for completed Washington State grant projects in the next quarter. Grant applications pending over $1 million could fund additional electrification site upgrades before divestiture.